The type of ATTR you have and how early it was diagnosed are two factors that can affect the prognosis of your disease.

Transthyretin-mediated (ATTR) amyloidosis is a multisystem disease caused by the abnormal deposition of misfolded transthyretin protein as amyloid fibrils in various tissues. ATTR amyloidosis presents ...

Amyloidosis is a complex disease and the program at Huntsman Cancer Institute (HCI) uses a collaborative approach to provide comprehensive medical care. Researchers are tirelessly trying to find new ...

The life expectancy for transthyretin (ATTR) amyloidosis varies from person to person. Your age, overall health, and primary symptoms all play a role. Transthyretin amyloidosis (ATTR) is a rare ...

DEAR DR. ROACH: I recently saw a friend who had been diagnosed with ALECT2 amyloidosis, a form of chronic kidney disease that is not well-understood but is considered fatal. Her illness was first ...

Interviewer: Amyloidosis is a rare and possibly debilitating disease, which affects about 4,000 people a year in the United States. If left untreated, the disease can cause severe organ damage, so ...

New Digital Health Community Delivers Rare Disease Resources and Peer Support for ATTR Amyloidosis Patients and Caregivers PHILADELPHIA, Dec. 11, 2025 /PRNewswire/ -- Health Union, the leading digital ...

Patients were classified by phenotype and genotype and assessed by a range of validated scales in common use internationally. The cardiac phenotype was the most predominant one globally, affecting ...

Protego Biopharma is poised to start pivotal trials of its amyloid light-chain (AL) amyloidosis drug candidate, thanks to a ...

An error has occurred. Please try again. With a Lewiston Sun Journal subscription, you can gift 5 articles each month. It looks like you do not have any active ...